Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast cancer suppression by aplysin is associated with inhibition of PI3K/AKT/FOXO3a pathway

Published:2017-07-12 Issue:38 Volume:8 Page:63923-63934
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Zhang Xinling¹,Zhuang Tingting²,Liang Zhengyan¹,Li Li²,Xue Meilan¹,Liu Jia¹,Liang Hui¹

Affiliation:

1. The Institute of Human Nutrition, Medical College of Qingdao University, Qingdao 266021, China

2. Key Laboratory of Marine Drugs, Chinese Ministry of Education, Key Laboratory of Glycoscience & Glycotechnology of Shandong Province, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gambogic Acid Suppresses Osteosarcoma Progression Through Upregulation of FOXO3a;2024-06-13

2. Natural bioactive compounds and FOXO3a in cancer therapeutics: An update;Fitoterapia;2024-03

3. AMPK Alchemy: Therapeutic Potentials in Allergy, Aging, and Cancer;Biomolecules & Therapeutics;2024-02-13

4. Integrated High-throughput Transcriptomic Data Identifies Survivin as a Potential Breast Cancer Therapeutic Biomarker;Current Medicinal Chemistry;2024-02

5. Therapeutic Consequences of Targeting the IGF-1/PI3K/AKT/FOXO3 Axis in Sarcopenia: A Narrative Review;Cells;2023-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP